Cargando…
Incorporation of membrane-bound, mammalian-derived immunomodulatory proteins into influenza whole virus vaccines boosts immunogenicity and protection against lethal challenge
BACKGROUND: Influenza epidemics continue to cause morbidity and mortality within the human population despite widespread vaccination efforts. This, along with the ominous threat of an avian influenza pandemic (H5N1), demonstrates the need for a much improved, more sophisticated influenza vaccine. We...
Autores principales: | Herbert, Andrew S, Heffron, Lynn, Sundick, Roy, Roberts, Paul C |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2679740/ https://www.ncbi.nlm.nih.gov/pubmed/19393093 http://dx.doi.org/10.1186/1743-422X-6-42 |
Ejemplares similares
-
Membrane-bound IL-12 and IL-23 serve as potent mucosal adjuvants when co-presented on whole inactivated influenza vaccines
por: Khan, Tila, et al.
Publicado: (2014) -
Mitigation of influenza-mediated inflammation by immunomodulatory matrix-bound nanovesicles
por: Crum, Raphael J., et al.
Publicado: (2023) -
Immunogenicity of HIV-1-Based Virus-Like Particles with Increased Incorporation and Stability of Membrane-Bound Env
por: Gonelli, Christopher A., et al.
Publicado: (2021) -
Advanced Oxidation Nanoprocessing Boosts Immunogenicity of Whole Tumor Cells
por: Zhang, Min, et al.
Publicado: (2023) -
THE IMMUNOGENICITY OF ANTIGEN BOUND TO THE PLASMA MEMBRANE OF MACROPHAGES
por: Unanue, Emil R., et al.
Publicado: (1970)